Masimo (NASDAQ:MASI) Reaches New 52-Week High – What’s Next?

Masimo Corporation (NASDAQ:MASI)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $179.00 and last traded at $178.69, with a volume of 1587310 shares trading hands. The stock had previously closed at $178.44.

Wall Street Analysts Forecast Growth

MASI has been the topic of several recent analyst reports. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a research note on Tuesday, February 17th. Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Finally, BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Masimo presently has a consensus rating of “Hold” and an average target price of $181.17.

Masimo Price Performance

The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average price is $156.72 and its two-hundred day moving average price is $147.49. The stock has a market cap of $9.60 billion, a P/E ratio of -16.95, a price-to-earnings-growth ratio of 1.81 and a beta of 1.21.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in MASI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after purchasing an additional 66 shares during the period. Clearstead Advisors LLC raised its holdings in Masimo by 18.4% in the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73 shares in the last quarter. Hantz Financial Services Inc. lifted its position in Masimo by 12.9% during the fourth quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock valued at $85,000 after buying an additional 75 shares during the period. Assetmark Inc. boosted its holdings in shares of Masimo by 5.5% during the 4th quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock valued at $241,000 after buying an additional 97 shares in the last quarter. Finally, Orion Porfolio Solutions LLC grew its position in shares of Masimo by 2.2% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock worth $819,000 after buying an additional 104 shares during the period. Hedge funds and other institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.